On March 12, 2021 Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, reported that Jay Roberts, Chief Executive Officer, will present at the Annual 33rd ROTH Conference (Press release, Cancer Genetics, MAR 12, 2021, View Source [SID1234576583]). The event is being held virtually from March 15-17, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Roberts will highlight the Company’s recent transformational business strategy, including the Company’s proposed merger with StemoniX, Inc., and elaborate on the broader going- forward corporate vision.

If you are an investor and would like to attend the Company’s presentation, please click on the following link (View Source) to register for the Annual 33rd ROTH Conference. Once your registration is confirmed, you will be prompted to log into the conference website and will be able to request a one-on-one meeting with the Company.

Cancer Genetics will also be available for outside virtual 1:1 meetings both during and after the Virtual Annual 33rd ROTH Conference. Please contact Jennifer K. Zimmons, Ph.D. [email protected] 917.214.3514 for scheduling.